SEARCH

SEARCH BY CITATION

References

  • 1
    . Guttadauria M, Ellman H, Emmanuel G, Kaplan D, Diamond H: Pulmonary function in scleroderma. Arthritis Rheum 20: 10711079, 1977
  • 2
    . Owens G, Fino G, Herbert D, Steen V, Medsger T, Pennock B, Cottrell J, Rodnan G, Rogers R: Pulmonary function in progressive systemic sclerosis: comparison of CREST syndrome variant with diffuse scleroderma. Chest 84: 546550, 1983
  • 3
    . Owens GR, Follansbee WP: Cardiopulmonary manifestations of systemic sclerosis. Chest 91: 118127, 1987
  • 4
    . Emmanuel G, Saroja D, Gopinathan K, Charpore A, Stuckey J: Environmental factors and the diffusing capacity of the lung in progressive systemic sclerosis. Chest 69 (suppl): 304, 1976
  • 5
    . Rodnan GP, Myerowitz RL, Justh GO: Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon. Medicine (Baltimore) 59: 393408, 1980
  • 6
    . Braunwald E: Mechanism of action of calcium-channel-blocking agents. N Engl J Med 307: 16181627, 1982
  • 7
    . Muller JE, Gunther SH: Nifedipine therapy for Prinz-metal's angina. Circulation 52: 237245, 1978
  • 8
    . Smith CD, McKendry RJR: Controlled trial of nifedipine in the treatment of Raynaud's phenomenon. Lancet II: 12991301, 1982
  • 9
    . Rodeheffer RJ, Rommer JA, Wigley F, Smith CR: Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon. N Engl J Med 308: 880883, 1984
  • 10
    . Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23: 581590, 1980
  • 11
    . LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15: 202205, 1988
  • 12
    . Ganz P, Swan HSC, Ganz W: Balloon-tippe. flow-directed catheters, Cardiac Catheterization and Angiography. Edited by WGrossman. Philadelphia, Lea & Febiger, 1986
  • 13
    . Grossman W: Bloo. flow measurement: the cardiac output, Cardiac Catheterization and Angiography. Edited by WGrossman. Philadelphia, Lea & Febiger, 1986
  • 14
    . Grossman W: Clinica. measurement of vascular resistance and assessment of vasodilator drugs, Catheterization and Angiography. Edited by WGrossman. Philadelphia, Lea & Febiger, 1986
  • 15
    . Golman HL, Becklake MR: Respiratory function tests: normal values at median altitudes and the prediction of normal results. Am Rev Tuberc 79: 457467, 1956
  • 16
    . Burrows B, Kasik JE, Nidan AH, Barclay WR: Clinical usefulness of the single breath pulmonary diffusing capacity test. Am Rev Respir Dis 84: 789806, 1961
  • 17
    . Nathan PS, Lebowitz MD, Knudson RJ: Spirometric testing: number of tests required and selection of data. Chest 76: 384388, 1979
  • 18
    . McCarthy DS, Baragar FD, Dhingra S, Sutherland JB, Rigby M, Martin L: The lungs in systemic sclerosis (scleroderma): a review and new information. Semin Arthritis Rheum 17: 271283, 1988
  • 19
    . Lally EV, Jimenez SA, Kaplan SR: Progressive systemic sclerosis: mode of presentation: rapidly progressive disease course and mortality based on an analysis of 91 patients. Semin Arthritis Rheum 18: 113, 1988
  • 20
    . D'Angelo W, Fries J, Masi A, Shulman L: Pathologic observations in systemic sclerosis: a study of 58 autopsy cases and 58 matched controls. Am J Med 46: 428440, 1969
  • 21
    . Sackner MA, Akgun N, Kimbell P, Lewis DH: The pathophysiology of scleroderma involving the heart and respiratory system. Ann Intern Med 60: 611630, 1964
  • 22
    . Young RH, Mark GJ: Pulmonary vascular changes in scleroderma. Am J Med 64: 9981004, 1978
  • 23
    . Furst DE, Davis JA, Clements PJ, Chopra SK, Theofilopoulos AN, Chia D: Abnormalities of pulmonary vascular dynamics and inflammation in early progressive systemic sclerosis. Arthritis Rheum 24: 14031408, 1981
  • 24
    . Naslund M, Pearson T, Ritter J: A documented episode of pulmonary vascoconstriction in systemic sclerosis. Johns Hopkins Med J 148: 7880, 1981
  • 25
    . Shuck JW, Oetgen WJ, Tesar JT: Pulmonary vascular response during Raynaud's phenomenon in progressive systemic sclerosis. Am J Med 78: 221227, 1985
  • 26
    . Wise RA, Wigley F, Newball HH, Stevens MB: The effect of cold exposure on diffusing capacity in patients with Raynaud's phenomenon. Chest 81: 695698, 1982
  • 27
    . Fahey PJ, Utell MJ, Condemi JJ, Green R, Hyde RW: Raynaud's phenomenon of the lung. Am J Med 76: 263269, 1984
  • 28
    . Wilson RJ, Rodnan GP, Robin GD: An early pulmonary physiologic abnormality in progressive systemic sclerosis (diffuse scleroderma). Am J Med 36: 361369, 1964
  • 29
    . Peters-Golden M, Wise RA, Hochberg MC, Wigley FM: Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis. Am J Med 77: 10271034, 1984
  • 30
    . Ungerer RG, Tashkin DP, Furst D, Clements PJ, Gong H, Bein M, Smith JW, Roberts N: Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med 75: 6574, 1983
  • 31
    . Murray JF: Th. Normal Lung: The Basis for Diagnosis and Treatment of Pulmonary Disease. Second edition. Philadelphia, WB Saunders, 1986
  • 32
    . Keogh AB, Crystal RG: Clinical significance of pulmonary function tests: pulmonary function testing in interstitial pulmonary disease: what does it tell us?? Chest 78: 856865, 1980